Teijin Pharma Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Teijin Pharma Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011353
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others. Its pharmaceutical pipeline products are intended for the treatment of tumor lysis syndrome, adenosine deaminase deficiency, optic neuritis, microscopic polyangiitis, neuroendocrine tumor, lumbar disc herniation, type 2 diabetes and others. Teijin Pharma’s home healthcare equipments include oxygen concentrators, sonic accelerated fracture healing system, and continuous positive airway pressure devices. The company has a presence in Europe, Asia and North America. Teijin Pharma is headquartered in Tokyo, Japan.

Teijin Pharma Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Teijin Pharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Teijin Pharma Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Teijin Pharma Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Teijin Pharma Enters into Distribution Agreement with SRETT 10
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 11
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 12
Teijin Pharma Ltd – Key Competitors 13
Teijin Pharma Ltd – Key Employees 14
Teijin Pharma Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Recent Developments 17
Corporate Communications 17
Feb 06, 2017: Teijin Board Elects Akihisa Nabeshima as New President of Teijin Pharma 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Teijin Pharma Ltd, Medical Equipment, Key Facts 2
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Teijin Pharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Teijin Pharma Ltd, Deals By Market, 2011 to YTD 2017 8
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Teijin Pharma Enters into Distribution Agreement with SRETT 10
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 11
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 12
Teijin Pharma Ltd, Key Competitors 13
Teijin Pharma Ltd, Key Employees 14
Teijin Pharma Ltd, Other Locations 15
Teijin Pharma Ltd, Subsidiaries 15
Teijin Pharma Ltd, Joint Venture 16

★海外企業調査レポート[Teijin Pharma Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ITV plc (ITV):企業の財務・戦略的SWOT分析
    ITV plc (ITV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sempra Energy (SRE):電力:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Trustpower Limited:企業の戦略的SWOT分析
    Trustpower Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Centogene AG-医療機器分野:企業M&A・提携分析
    Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Cent …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Syneron Medical Ltd:企業の戦略的SWOT分析
    Syneron Medical Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Grid2020, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Israel Military Industries Ltd.:企業の戦略・SWOT・財務情報
    Israel Military Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Military Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and markets intradermal delivery solutions for vaccines and drugs. The company offers product such as MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its products are used wit …
  • FLX Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The company’s pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a secon …
  • Vision Ease LP:企業の戦略的SWOT分析
    Vision Ease LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Hwange Colliery Co Ltd:企業の戦略・SWOT・財務分析
    Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Marubeni Power International Inc:電力:M&Aディール及び事業提携情報
    Summary Marubeni Power International Inc (Marubeni Power International), formerly National Power Development Inc, a subsidiary of Marubeni Corp, is an energy service provider that offers electricity generation and transmission services. The company acquires established power generation portfolios an …
  • Enzo Biochem Inc (ENZ):企業の財務・戦略的SWOT分析
    Enzo Biochem Inc (ENZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆